# OnCo record paper-destiny-lung01-nejm-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-destiny-lung01-nejm-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-destiny-lung01-nejm-2022" ;
  schema:name "DESTINY-Lung01: trastuzumab deruxtecan in HER2-mutant non-small-cell lung cancer"@en ;
  schema:description "Trastuzumab deruxtecan shrank tumours in more than half of patients with previously treated HER2-mutant lung cancer, a driver with no approved therapy until this study, though lung inflammation was a serious side effect."@en ;
  schema:url <https://onco.cc/key-papers/paper-destiny-lung01-nejm-2022/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2112431>, <https://pubmed.ncbi.nlm.nih.gov/34534430/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2112431> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Li BT, Smit EF, Goto Y, et al." ;
  onco:cancers <https://onco.cc/cancers/her2-mutant-nsclc/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:trials <https://onco.cc/trials/destiny-lung01/> ;
  onco:journals <https://onco.cc/journals/nejm/> .